JPMorgan lowered the firm’s price target on DocuSign (DOCU) to $77 from $81 and keeps a Neutral rating on the shares. The company’s fiscal Q1 results were dragged down by an “uncharacteristic” billings miss and downward fiscal 2026 billings outlook revision on lower early renewals, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCU:
- DocuSign price target lowered to $80 from $85 at UBS
- DocuSign price target lowered to $85 from $93 at Baird
- DocuSign price target lowered to $86 from $92 at Morgan Stanley
- DocuSign’s Transitional Challenges and Strategic Investments Lead to Hold Rating
- DocuSign price target raised to $67 from $65 at Wells Fargo